Exchange Protein directly Activated by cAMP (EPAC): Structure, Function and Therapeutics

cAMP 直接激活的交换蛋白 (EPAC):结构、功能和治疗

基本信息

项目摘要

PROJECT SUMMARY This is an R35 application in response to RFA-GM-17-002 “Maximizing Investigators’ Research Award (R35)". Our laboratory focuses on studying the pleiotropic second messenger cyclic AMP (cAMP) system. cAMP is a major stress signal that regulates a myriad of important biological processes under both physiological and pathological conditions, including cancer, chronic pain, diabetes, heart failure, and infections. Hence, not surprisingly, the cAMP signaling cascade is one of the most targeted pathways by current pharmaceuticals. In multi-cellular eukaryotic organisms, the effects of cAMP are mainly transduced by two ubiquitously-expressed intracellular cAMP receptors, the classic protein kinase A/cAMP-dependent protein kinase (PKA/cAPK) and the more recently discovered exchange proteins directly activated by cAMP/cAMP-regulated guanine nucleotide exchange factor (EPAC/cAMP-GEF). While accumulating evidence implicates EPAC proteins as important stress response switches in the development of various human diseases, major gaps in our basic understanding of EPAC structures and functions persist. To bridge these gaps, we will apply structural, pharmacological and genetic approaches to interrogate the mechanisms of action and biological functions of this important family of signaling molecules, leading to the assessment of EPAC proteins as potential therapeutic targets in various disease models. The proposed research is based on more than seventeen years of extensive fundamental studies of EPAC-mediated signaling and directly builds on a several recent developments in our laboratory, which include the characterization of EPAC knockout mice and the discovery of first-in-class EPAC specific inhibitors. The combination of complementary structural approaches, novel genetic animal models and pharmacological probes will enable us to reveal much desired mechanistic insight and in vivo functions of EPAC proteins. This research plan will also aid in the advancement of new pharmacological tools for deciphering EPAC-mediated cell signaling and disease mechanisms, which can pave the way for novel, mechanism-based therapeutic strategies specifically targeting cAMP/EPAC signaling.
项目摘要 这是响应RFA-GM-17-002“最大化研究者研究奖(R35)”的R35申请。 本实验室致力于研究多效性第二信使环腺苷酸(cAMP)系统。营是一个 主要的压力信号,调节无数重要的生物过程下的生理和 病理状况,包括癌症、慢性疼痛、糖尿病、心力衰竭和感染。因此不 令人惊讶的是,cAMP信号级联是目前药物最具靶向的途径之一。在 在多细胞真核生物中,cAMP的作用主要通过两种普遍表达的 细胞内cAMP受体,经典的蛋白激酶A/cAMP依赖性蛋白激酶(PKA/cAPK)和 最近发现的由cAMP/cAMP调节的鸟嘌呤直接激活的交换蛋白 核苷酸交换因子(EPAC/cAMP-GEF)。虽然越来越多的证据表明EPAC蛋白是 重要的压力反应开关在各种人类疾病的发展,主要差距,我们的基本 对EPAC结构和功能的理解仍然存在。为了弥合这些差距,我们将采用结构, 药理学和遗传学的方法来询问的作用机制和生物学功能, 这一重要的信号分子家族,导致评估EPAC蛋白作为潜在的 各种疾病模型中的治疗靶点。这项研究是基于17年多的 EPAC介导的信号传导的广泛基础研究,并直接建立在最近的几个 我们实验室的发展,其中包括EPAC敲除小鼠的特征和发现 一流的EPAC特异性抑制剂互补结构方法的组合,新颖 遗传动物模型和药理学探针将使我们能够揭示更渴望的机制见解 以及EPAC蛋白的体内功能。这项研究计划还将有助于推动新的 用于破译EPAC介导的细胞信号传导和疾病机制的药理学工具, 新的,基于机制的治疗策略,特别是针对cAMP/EPAC信号的方式。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
Origin and Isoform Specific Functions of Exchange Proteins Directly Activated by cAMP: A Phylogenetic Analysis.
  • DOI:
    10.3390/cells10102750
  • 发表时间:
    2021-10-14
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Ni Z;Cheng X
  • 通讯作者:
    Cheng X
Compartmentalized cyclic nucleotides have opposing effects on regulation of hypertrophic phospholipase Cε signaling in cardiac myocytes.
区室化的环核苷酸对心肌细胞中肥大性磷脂酶 Cγ 信号传导的调节具有相反的作用。
  • DOI:
    10.1016/j.yjmcc.2018.06.002
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Nash,CraigA;Brown,LorenM;Malik,Sundeep;Cheng,Xiaodong;Smrcka,AlanV
  • 通讯作者:
    Smrcka,AlanV
Epac1 (Exchange Protein Directly Activated by cAMP 1) Upregulates LOX-1 (Oxidized Low-Density Lipoprotein Receptor 1) to Promote Foam Cell Formation and Atherosclerosis Development.
Protein SUMOylation and phase separation: partners in stress?
  • DOI:
    10.1016/j.tibs.2022.12.003
  • 发表时间:
    2023-05
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    Cheng, Xiaodong
  • 通讯作者:
    Cheng, Xiaodong
Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors.
与四氢喹啉类似物作为EPAC抑制剂的结构活性关系研究。
  • DOI:
    10.1021/acsmedchemlett.7b00358
  • 发表时间:
    2017-11-09
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Sonawane YA;Zhu Y;Garrison JC;Ezell EL;Zahid M;Cheng X;Natarajan A
  • 通讯作者:
    Natarajan A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

XIAODONG CHENG其他文献

XIAODONG CHENG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('XIAODONG CHENG', 18)}}的其他基金

Significance of Epac signaling in renal Na+ handling and hypertension
Epac 信号在肾钠处理和高血压中的意义
  • 批准号:
    10864073
  • 财政年份:
    2023
  • 资助金额:
    $ 42.85万
  • 项目类别:
Epac1 as a novel therapeutic target for diabetic retinopathy
Epac1作为糖尿病视网膜病变的新型治疗靶点
  • 批准号:
    10689112
  • 财政年份:
    2022
  • 资助金额:
    $ 42.85万
  • 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
  • 批准号:
    9250048
  • 财政年份:
    2014
  • 资助金额:
    $ 42.85万
  • 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
  • 批准号:
    9038248
  • 财政年份:
    2014
  • 资助金额:
    $ 42.85万
  • 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
  • 批准号:
    8694342
  • 财政年份:
    2014
  • 资助金额:
    $ 42.85万
  • 项目类别:
Novel Pharmacological Probes Targeting Exchange Proteins Activated by cAMP (EPAC)
针对 cAMP 激活的交换蛋白的新型药理学探针 (EPAC)
  • 批准号:
    8482964
  • 财政年份:
    2013
  • 资助金额:
    $ 42.85万
  • 项目类别:
High throughput assay for novel pharmacological probes targeting cAMP signaling
针对 cAMP 信号传导的新型药理学探针的高通量测定
  • 批准号:
    8477859
  • 财政年份:
    2010
  • 资助金额:
    $ 42.85万
  • 项目类别:
High throughput assay for novel pharmacological probes targeting cAMP signaling
针对 cAMP 信号传导的新型药理学探针的高通量测定
  • 批准号:
    7991500
  • 财政年份:
    2010
  • 资助金额:
    $ 42.85万
  • 项目类别:
Genetic Screening:Oncogene RAS-Based Inhibi*(RMI)
基因筛查:Oncogene RAS-Based Inhibi*(RMI)
  • 批准号:
    7058055
  • 财政年份:
    2005
  • 资助金额:
    $ 42.85万
  • 项目类别:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
Epac/cAMP-GEF,一种新型细胞内 cAMP 受体
  • 批准号:
    6743684
  • 财政年份:
    2003
  • 资助金额:
    $ 42.85万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 42.85万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 42.85万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 42.85万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 42.85万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 42.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 42.85万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 42.85万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 42.85万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 42.85万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 42.85万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了